Idarucizumab 12714-0196
Product NDC
12714-0196- Manufacturer
- Boehringer Ingelheim Pharma Gmbh And Co. Kg
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- October 21, 2015
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Idarucizumab | 50 mg/50mg |
Packaging Options(1)
50 mg in 1 VIAL, SINGLE-DOSE (12714-196-50)